Article
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis.
Clinical drug investigation - 1 Nov 2017
Ahmed Hussien, Abushouk Abdelrahman Ibrahim, Menshawy Amr, Mohamed Arwa, Negida Ahmed, Loutfy Samah A, Abdel-Daim Mohamed M
Abstract excerpt
BACKGROUND AND OBJECTIVE: Interferon-free regimens are rapidly evolving for patients with chronic hepatitis C virus (HCV) infection. We performed this meta-analysis to investigate the safety and efficacy of a combination regimen (ombitasvir [OBV]/paritaprevir [PTV]/ritonavir [r] ± dasabuvir [DSV]) for the treatment of patients with HCV genotype 1 infection. METHODS: A computerized literature search for relevant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.